✦ LIBER ✦

Parkinson's disease, levodopa-use and the risk of melanoma

✍ Scribed by J.-D. Vermeij; A. Winogrodzka; J. Trip; W.E.J. Weber

Book ID: 116820660
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 98 KB
Volume: 15
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2009.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Parkinson's disease, levodopa-use and th

Parkinson's disease, levodopa-use and the risk of melanoma

✍ J.-D. Vermeij; A. Winogrodzka; J. Trip; W.E.J. Weber 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Since the early 1970s, the literature has suggested an association between Parkinson's Disease (PD) and/ or levodopa-use and an increased risk for the development of malignant melanoma. In some countries, this possible association has even led to a warning in the drug insert leaflet of the possible

Parkinson's disease, melanoma, and levod

Parkinson's disease, melanoma, and levodopa

✍ Joseph Fermaglich; Peyton Delaney 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 239 KB

Malignant melanoma and levodopa in Parki

Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?

✍ Katherine H Fiala; Jacqueline Whetteckey; Bala V Manyam 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Levodopa and the progression of Parkinso

Levodopa and the progression of Parkinson’s disease

✍ John Morgan; Kapil D. Sethi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 194 KB

Using Liquid Levodopa in the Treatment o

Using Liquid Levodopa in the Treatment of Parkinson’s Disease

✍ Dr Matthias C. Kurth 📂 Article 📅 1997 🏛 Springer International Publishing AG 🌐 English ⚖ 885 KB

Levodopa and the risk of melanoma

✍ Roberto Zanetti; Stefano Rosso 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 40 KB